Double maintains 3 strategies that include TFX - Teleflex, Inc.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PDBC | 0.13% | $4.54B | 0.59% |
FMF | 0.16% | $157.02M | 0.95% |
BSMW | 0.24% | $104.76M | 0.18% |
STIP | 0.25% | $12.60B | 0.03% |
XONE | -0.29% | $639.76M | 0.03% |
BIL | 0.30% | $43.88B | 0.1356% |
USCI | 0.56% | $242.50M | 1.07% |
SPTS | 0.62% | $5.79B | 0.03% |
VTIP | -0.67% | $15.13B | 0.03% |
TFLO | 0.85% | $6.90B | 0.15% |
TPMN | -0.85% | $30.86M | 0.65% |
KMLM | 0.93% | $188.63M | 0.9% |
UNG | 1.06% | $347.39M | 1.06% |
GSG | -1.16% | $967.65M | 0.75% |
GBIL | -1.26% | $6.18B | 0.12% |
DBC | -1.34% | $1.26B | 0.87% |
AGZD | -1.70% | $111.95M | 0.23% |
VGSH | 1.97% | $22.49B | 0.03% |
SGOV | 2.05% | $48.91B | 0.09% |
SCHO | 2.10% | $10.94B | 0.03% |
Yahoo
A company with profits isn’t always a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
Yahoo
WAYNE, Pa., June 12, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced findings from a new multinational study reporting efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters (CVCs). This prospective cohort study included more than 6,670 patients from 12 Intensive care units in eight hospitals across India, Malaysia, Papua New Guinea, Colombia, Egypt and Turkey. Key highlights include: The pre-specified
Finnhub
WAYNE - Teleflex Incorporated , a leading global provider of medical technologies, announced two bold awareness initiatives in conjunction with Men's Health Month to raise awareness for...
Finnhub
Teleflex Incorporated announced findings from a new multinational study reporting efficacy of Arrow Chlorhexidine-Impregnated Central Venous Catheters . This prospective cohort study included more...
Yahoo
Timed with National Men’s Health Month, the Prostate Monster ad campaign shines a light on quality-of-life issues associated with benign prostatic hyperplasia or BPH—a condition affecting millions of men1—and encourages them to take control of their health. The Teleflex Prostate Education Express, a mobile training and education center, is on a national tour to educate physicians and the community on prostate health quality-of-life issues associated with BPH and the importance of organ spacing t
SeekingAlpha
For the quarter, US stocks fell -4.7% (as measured by the Russell 3000 Index), notching marketsâ first quarterly decline since Q3 2023. Read more here.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -26.61% | $196.95M | 0.85% |
TAIL | -25.63% | $104.04M | 0.59% |
BTAL | -19.64% | $296.94M | 1.43% |
IVOL | -13.62% | $346.82M | 1.02% |
UGA | -13.36% | $77.18M | 0.97% |
DBE | -9.62% | $52.31M | 0.77% |
USO | -8.77% | $1.20B | 0.6% |
BNO | -8.40% | $97.13M | 1% |
KCCA | -8.36% | $98.85M | 0.87% |
USL | -7.58% | $43.35M | 0.85% |
OILK | -7.46% | $74.96M | 0.69% |
SHYM | -5.63% | $324.29M | 0.35% |
ULST | -5.58% | $667.74M | 0.2% |
DBO | -5.31% | $223.97M | 0.77% |
FTSD | -5.17% | $228.45M | 0.25% |
STOT | -5.10% | $239.87M | 0.45% |
CLIP | -4.96% | $1.50B | 0.07% |
UUP | -4.23% | $156.34M | 0.77% |
FXY | -4.22% | $859.86M | 0.4% |
COMT | -3.67% | $634.74M | 0.48% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MQ | -0.10% | $2.62B | +9.82% | 0.00% |
NTNX | -0.12% | $19.74B | +37.87% | 0.00% |
TBPH | 0.16% | $530.01M | +25.00% | 0.00% |
RELY | 0.22% | $4.21B | +75.36% | 0.00% |
CME | 0.24% | $97.19B | +37.23% | 3.92% |
MPW | 0.25% | $2.67B | -7.69% | 5.46% |
DNB | -0.25% | $4.05B | +1.68% | 1.65% |
VTOL | -0.27% | $981.24M | +3.27% | 0.00% |
BTCT | 0.29% | $19.82M | +38.12% | 0.00% |
FPI | 0.30% | $525.21M | -1.14% | 2.09% |
NXTC | 0.44% | $12.66M | -65.80% | 0.00% |
ARGX | -0.44% | $33.02B | +43.06% | 0.00% |
SAVA | 0.45% | $100.00M | -89.39% | 0.00% |
LZ | -0.46% | $1.55B | +5.67% | 0.00% |
LAUR | 0.46% | $3.34B | +57.65% | 0.00% |
STRL | 0.64% | $6.73B | +80.44% | 0.00% |
FMX | -0.69% | $21.12B | -4.06% | 4.36% |
ALXO | -0.70% | $26.47M | -92.85% | 0.00% |
CMTL | 0.72% | $58.20M | -51.35% | 0.00% |
EE | 0.90% | $954.46M | +70.55% | 0.69% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
RSPH | 53.88% | $743.58M | 0.4% |
XHE | 53.04% | $174.77M | 0.35% |
FXH | 52.08% | $904.53M | 0.62% |
IHI | 51.90% | $4.52B | 0.4% |
MOAT | 47.24% | $12.53B | 0.47% |
FHLC | 47.02% | $2.47B | 0.084% |
IYH | 46.89% | $2.77B | 0.39% |
VHT | 46.81% | $15.53B | 0.09% |
XLV | 45.06% | $34.81B | 0.09% |
KNG | 43.64% | $3.73B | 0.75% |
NOBL | 43.50% | $11.34B | 0.35% |
FIW | 43.23% | $1.82B | 0.51% |
SDY | 43.10% | $19.81B | 0.35% |
FVD | 43.03% | $9.02B | 0.61% |
IXJ | 42.96% | $3.82B | 0.41% |
IHE | 42.91% | $574.16M | 0.39% |
DSTL | 42.10% | $1.82B | 0.39% |
RSP | 41.67% | $70.52B | 0.2% |
PINK | 41.63% | $131.84M | 0.5% |
QQQJ | 41.30% | $603.36M | 0.15% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
VTRS | 55.35% | $10.28B | -12.84% | 5.46% |
ECPG | 53.49% | $891.01M | -6.93% | 0.00% |
DMRC | 50.66% | $275.43M | -50.45% | 0.00% |
A | 50.16% | $32.98B | -13.94% | 0.84% |
FE | 50.08% | $22.92B | +4.06% | 4.33% |
WPP | 49.27% | $7.60B | -24.98% | 7.16% |
ARW | 48.78% | $6.44B | -1.31% | 0.00% |
APTV | 47.66% | $14.72B | -4.28% | 0.00% |
RVTY | 46.98% | $11.10B | -12.24% | 0.30% |
WAT | 46.63% | $20.30B | +15.86% | 0.00% |
IBTA | 46.60% | $1.12B | -45.50% | 0.00% |
AIN | 45.27% | $2.04B | -20.47% | 1.57% |
IQV | 45.27% | $26.66B | -27.59% | 0.00% |
TECH | 45.06% | $7.76B | -33.59% | 0.65% |
BDX | 44.37% | $48.71B | -27.29% | 2.40% |
XRAY | 43.92% | $3.06B | -40.10% | 4.14% |
TWI | 43.77% | $575.25M | +22.86% | 0.00% |
SNN | 43.00% | $12.53B | +13.88% | 2.63% |
FA | 42.98% | $3.05B | +8.27% | 0.00% |
ASH | 42.81% | $2.24B | -49.69% | 3.29% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ROOT | -28.33% | $2.17B | +208.61% | 0.00% |
UUU | -28.17% | $7.19M | +94.38% | 0.00% |
ATEC | -25.85% | $1.59B | +4.53% | 0.00% |
SXC | -16.50% | $701.76M | -13.91% | 5.77% |
PSTL | -14.36% | $357.97M | +13.36% | 6.47% |
HEI | -11.84% | $42.72B | +34.24% | 0.07% |
HUSA | -11.82% | $31.37M | +61.29% | 0.00% |
MYRG | -11.65% | $2.59B | +19.47% | 0.00% |
RBLX | -11.31% | $68.59B | +181.67% | 0.00% |
CPSH | -11.10% | $36.32M | +44.51% | 0.00% |
ARIS | -10.96% | $844.44M | +81.29% | 1.89% |
RRGB | -10.08% | $92.40M | -30.99% | 0.00% |
HEI.A | -9.84% | $33.26B | +32.72% | 0.09% |
SSSS | -9.29% | - | - | 0.00% |
FMTO | -8.40% | $4.80K | -99.93% | 0.00% |
SPOK | -8.40% | $340.06M | +14.32% | 7.56% |
XNET | -8.29% | $291.90M | +175.29% | 0.00% |
CBOE | -8.18% | $23.60B | +33.06% | 1.12% |
ETR | -8.08% | $34.88B | +52.72% | 4.36% |
MEG | -7.52% | $795.18M | -52.42% | 0.00% |
Current Value
$117.891 Year Return
Current Value
$117.891 Year Return